greeksoup/ stock research

Dentsply Sirona (XRAY) FY2021 results: revenue $4.2 billion, up 26.6% on the year

Dentsply Sirona Inc. (XRAY) reported revenue of $4.2 billion for fiscal 2021, the year ended 31 December 2021, up 26.6% on the year before. Net income was $411 million, and diluted earnings per share $1.87. The figures are the company's own, from the 10-K it filed with the SEC on 1 March 2022.

Revenue
$4.2 billion
+26.6% on the year
FY2014FY2021
Operating margin
14.4%
-0.1% a year earlier
FY2014FY2021
Net income
$411 million
FY2014FY2021
Diluted EPS
$1.87
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue4,2313,3424,029+26.6%
Cost of revenue1,8841,6851,858+11.8%
Gross profit2,3471,6572,165+41.6%
Gross margin55.5%49.6%53.7%
Research and development171123143+39.0%
Selling, general and administrative1,5511,3021,587+19.1%
Operating income608-3.0353
Operating margin14.4%-0.1%8.8%
Interest expense61.048.030.0+27.1%
Pre-tax income545-50.0338
Income tax13423.082.0+482.6%
Effective tax rate24.6%n/a24.3%
Net income411-73.0256
Net margin9.7%-2.2%6.4%
Diluted EPS$1.87-$0.33$1.14
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow657649639+1.2%
Capital expenditure14287.0123+63.2%
Free cash flow515562516-8.4%
Free cash flow margin12.2%16.8%12.8%
Cash from investing-358-1,106-69.0
Cash from financing-379476-472
Depreciation and amortisation347334323+3.9%
Share-based compensation48.047.066.0+2.1%
Buybacks200140260+42.9%
Dividends paid92.088.080.9+4.5%
Dividend per share$0.43$0.40$0.38+7.5%
Diluted shares, weighted220m219m224m+0.5%
Shares outstanding at period end217m219m221m-0.6%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity4,9964,9325,092+1.3%
Non-controlling interest1.03.02.0-66.7%
Debt2,0952,2841,438-8.3%
Operating lease liabilities149130120+14.6%
Finance lease liabilities1.01.01.00.0%
Other liabilities1,9971,9921,950+0.3%
Total liabilities and equity9,2399,3428,603-1.1%
Fixed assets773791802-2.3%
Goodwill3,9763,9863,396-0.3%
Intangible assets2,3192,5042,176-7.4%
Cash and equivalents339438405-22.6%
Inventory515476562+8.2%
Other assets1,3171,1471,261+14.8%
Total assets9,2399,3428,603-1.1%

10-K for the year ended 31 December 2021, filed 1 March 2022: the filing.